
Experience
Travere Sells Bile Acid Product Portfolio to Mirum
July 18, 2023
Cooley advised Travere Therapeutics, a biopharmaceutical company, on its definitive agreement to sell its bile acid product portfolio to Mirum Pharmaceuticals.
Related contacts
Related Practices & Industries
Absolute Software Announces $870 Million Acquisition by Crosspoint Capital
May 15, 2023
Cooley advised Absolute Software, a data risk management solutions and endpoint security provider, on its acquisition by Crosspoint Capital for approximately $870 million, inclusive of debt.
Related contacts
Related Practices & Industries
Redx Pharma to Merge With Jounce Therapeutics
March 6, 2023
Cooley advised Redx Pharma, a UK clinical-stage biotechnology company, on its all share merger with Jounce Therapeutics, a US clinical-stage immunotherapy company, in a $425 million and contingent value right transaction.
Related contacts
Oyster Point Pharma to Be Acquired by Viatris
November 10, 2022
Cooley advised Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, on its definitive agreement to be acquired by global healthcare company Viatris. Partners Mika Reiner Mayer, Brandon Fenn, Div Gupta and Ian Nussbaum led the Cooley team advising Oyster Point Pharma.
Related contacts
Related Practices & Industries
Amazon to Acquire One Medical for $3.9 Billion
July 28, 2022
Cooley, which represents more than 600 digital health clients across the healthcare ecosystem, advised One Medical, a human-centered, technology-powered national primary care organization, on a definitive merger agreement under which Amazon will acquire One Medical for $18 per share in an all-cash transaction valued at approximately $3.9 billion, including One Medical’s net debt. Lawyers Steven Tonsfeldt, Matthew Hemington, Anne Lieberman and Gaël Hagan are leading the Cooley team advising One Medical.